Elevance HealthELVEarnings & Financial Report
Elevance Health, Inc. is an American health insurance company. Prior to June 2022, Elevance Health was named Anthem, Inc. The company is the world's seventh largest healthcare company based on revenue. Its services include medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans through affiliated companies such as Anthem Blue Cross and Blue Shield, Anthem Blue Cross in California, Wellpoint, and Carelon.
ELV Q1 FY2026 Key Financial Metrics
Revenue
$49.7B
Gross Profit
$44.2B
Operating Profit
$309.0M
Net Profit
$547.0M
Gross Margin
88.9%
Operating Margin
0.6%
Net Margin
1.1%
YoY Growth
1.8%
EPS
$2.56
Elevance Health Q1 FY2026 Financial Summary
Elevance Health reported revenue of $49.7B (up 1.8% YoY) for Q1 FY2026, with a net profit of $547.0M (down 74.9% YoY) (1.1% margin). Cost of goods sold was $5.5B, operating expenses totaled $43.9B.
Key Financial Metrics
| Total Revenue | $49.7B |
|---|---|
| Net Profit | $547.0M |
| Gross Margin | 88.9% |
| Operating Margin | 0.6% |
| Report Period | Q1 FY2026 |
Elevance Health Annual Revenue by Year
Elevance Health annual revenue history includes year-by-year totals (for example, 2025 revenue was $199.1B).
Elevance Health Quarterly Revenue & Net Profit History
Elevance Health results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q1 FY2026 | $49.7B | +1.8% | $547.0M | 1.1% |
| Q4 FY2025 | $49.7B | +9.5% | $547.0M | 1.1% |
| Q3 FY2025 | $50.7B | +12.4% | $1.2B | 2.3% |
| Q2 FY2025 | $49.8B | +13.4% | $1.7B | 3.5% |
| Q1 FY2025 | $48.9B | +14.8% | $2.2B | 4.5% |
| Q4 FY2024 | $45.4B | +6.6% | $418.0M | 0.9% |
| Q3 FY2024 | $45.1B | +5.3% | $1.0B | 2.3% |
| Q2 FY2024 | $43.9B | +0.5% | $2.3B | 5.2% |
Income Statement
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $43.89B | $45.11B | $45.44B | $48.89B | $49.78B | $50.71B | $49.75B | $49.75B |
| YoY Growth | 0.5% | 5.3% | 6.6% | 14.8% | 13.4% | 12.4% | 9.5% | 1.8% |
Balance Sheet
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $112.99B | $116.53B | $116.89B | $119.72B | $121.94B | $122.75B | $121.49B | $121.49B |
| Liabilities | $70.69B | $72.65B | $75.46B | $77.10B | $78.09B | $78.67B | $77.47B | $77.47B |
| Equity | $42.19B | $43.77B | $41.31B | $42.50B | $43.72B | $43.95B | $43.88B | $43.88B |
Cash Flow
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|
| Operating CF | $447.0M | $2.68B | $706.0M | $1.02B | $2.05B | $1.14B | $84.0M |